![](https://i.imgur.com/CLvY2jA.png")
08-04-2022, 01:34 PM
Sinovac has protection against severe cases was 85% ( 95% CI 59.4–94.8 ), and there were no deaths among pregnant women who received at least one dose of Sinovac.
As the world's first officially published research on the protective effect of the new coronavirus inactivated vaccine on pregnant women in the real world, this study fills the lack of evidence of the effectiveness of the domestically produced new coronavirus inactivated vaccine in pregnant women.
The results of a safety analysis involving more than 100,000 Brazilian pregnant women, conducted by SINOVAC in cooperation with IQVIA Brazil, also showed that Sinovac showed good safety in the pregnant and lying -in women.
Compared with the new crown vaccine of other technology platforms, the incidence of adverse events of Sinovac is lower .
The results of the study on the good safety and significant efficacy of Sinovac in pregnant women, in the context of the COVID - 19 epidemic swept across the world in various countries and regions, the study is for the application of Sinovac in pregnant women to reduce the new crown virus.
http://www.sinovac.com.cn/news/shownews.php?id=1431
As the world's first officially published research on the protective effect of the new coronavirus inactivated vaccine on pregnant women in the real world, this study fills the lack of evidence of the effectiveness of the domestically produced new coronavirus inactivated vaccine in pregnant women.
The results of a safety analysis involving more than 100,000 Brazilian pregnant women, conducted by SINOVAC in cooperation with IQVIA Brazil, also showed that Sinovac showed good safety in the pregnant and lying -in women.
Compared with the new crown vaccine of other technology platforms, the incidence of adverse events of Sinovac is lower .
The results of the study on the good safety and significant efficacy of Sinovac in pregnant women, in the context of the COVID - 19 epidemic swept across the world in various countries and regions, the study is for the application of Sinovac in pregnant women to reduce the new crown virus.
http://www.sinovac.com.cn/news/shownews.php?id=1431
